Below are some of the unlisted options held by Nina (per annual report):
Nina is a very competent CEO/MD, if Phase3 trial is successful, she should be rewarded in some way imo even if the above options are fully expired/lapsed (looks like so. just don't understand why they initially put expiry date on exactly same time/date yet with different exercise prices hope it was a mistake and the expiry date with higher exe price is actually in a bit later years)..
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ, page-343
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $214.7M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 41.0¢ | 38.5¢ | $1.104M | 2.784M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5501 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 7500 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |